Also, after 12 weeks of treatment, compared with CLAT, the expression of urinary TGF-β1 and MCP-1 decreased significantly in the TLF + CLAT group, which showed that TLF combined with CLAT has benefits in protecting against renal fibrosis. The gene discussed is CCL2; the disease is renal fibrosis.